This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Ann & Robert H. Lurie Children's Hospital of Chicago, Children's Memorial Hospital, Ann & Robert H. Lurie Children's Hosp. of Chicago. Active years: 2010-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 19 
2 out of 5 
1 out of 1 Years Active: 2010-2019
Title: Elisabeth Ann Seftor: Innovator in Anti-Nodal Antibodies
Introduction
Elisabeth Ann Seftor is a prominent inventor based in Chicago, IL, known for her significant contributions to the field of medical research. With a total of seven patents to her name, she has made remarkable strides in the development of anti-Nodal antibodies, which have potential applications in diagnosing, preventing, and treating Nodal-related disorders.
Latest Patents
Among her latest patents is the invention titled "Anti-nodal antibodies and methods of using same." This invention focuses on the use of anti-Nodal antibodies for diagnosing, preventing, and treating disorders associated with Nodal. The innovative approach presented in her patents showcases her dedication to advancing medical science and improving patient outcomes.
Career Highlights
Elisabeth has worked with esteemed institutions such as Ann & Robert H. Lurie Children's Hospital of Chicago and Children's Memorial Hospital. Her experience in these organizations has allowed her to collaborate with leading professionals in the medical field, further enhancing her expertise and impact.
Collaborations
Some of her notable coworkers include Mary Jessica Hendrix and Richard Edward Barnet Seftor. Their collaborative efforts have contributed to the success of her research and the development of her patents.
Conclusion
Elisabeth Ann Seftor's work in the field of anti-Nodal antibodies exemplifies her commitment to innovation and medical advancement. Her contributions continue to pave the way for new treatments and improved healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile